Original Research

Published on 14 Jun 2022

Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma

in Thoracic Oncology

Juan Wang
Yixiao Yuan
Lin Tang
Haoqing Zhai
Dahang Zhang
Lincan Duan
Xiulin Jiang
Chen Li

Frontiers in Oncology

doi 10.3389/fonc.2022.921200

3,565 views
28 citations

Original Research

Published on 14 Jun 2022

A Prognostic Model of Non-Small Cell Lung Cancer With a Radiomics Nomogram in an Eastern Chinese Population

in Thoracic Oncology

Lijie Wang
Ailing Liu
Zhiheng Wang
Ning Xu
Dandan Zhou
Tao Qu
Guiyuan Liu
Jingtao Wang
Fujun Yang
Xiaolei Guo

Frontiers in Oncology

doi 10.3389/fonc.2022.816766

2,917 views
5 citations

Systematic Review

Published on 14 Jun 2022

Beyond Crizotinib: A Systematic Review and Meta-Analysis of the Next-Generation ALK Inhibitors as First-Line Treatment for ALK-Translocated Lung Cancer

in Thoracic Oncology

Emilio Francesco Giunta
Alessio Signori
Howard Jack West
Giulio Metro
Alex Friedlaender
Kaushal Parikh
Giuseppe Luigi Banna
Alfredo Addeo

Frontiers in Oncology

doi 10.3389/fonc.2022.921854

4,795 views
5 citations

Systematic Review

Published on 10 Jun 2022

Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Haiyan Zeng
Danyang Zheng
Willem J. A. Witlox
Antonin Levy
Alberto Traverso
Feng-Ming (Spring) Kong
Ruud Houben
Dirk K. M. De Ruysscher
Lizza E. L. Hendriks

Frontiers in Oncology

doi 10.3389/fonc.2022.889161

4,233 views
7 citations

Original Research

Published on 10 Jun 2022

The Applicability of the Results in the Asian Population of ORIENT-11 to a Western Population According to the ICH-E5 Framework

in Thoracic Oncology

Stephen V. Liu
Misako Nagasaka
Victoria Stefaniak
Kristi Gruver
Yong Lin
David Ferry
Mark A. Socinski
Li Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.859892

5,112 views
2 citations

Original Research

Published on 08 Jun 2022

Platelet Activation in High D-Dimer Plasma Plays a Role in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Mutant Lung Adenocarcinoma

in Thoracic Oncology

Meng-Jung Lee
Chih-Ming Weng
Wei Chao
Yueh-Fu Fang
Fu-Tsai Chung
Chien-Huang Lin
Han-Pin Kuo

Frontiers in Oncology

doi 10.3389/fonc.2022.876051

41,962 views
2 citations

Original Research

Published on 08 Jun 2022

Plasma CXCL14 as a Candidate Biomarker for the Diagnosis of Lung Cancer

in Thoracic Oncology

Peng-Fei Tian
Yu-Chen Ma
Dong-Sheng Yue
Fan Liang
Chen-Guang Li
Chen Chen
Hua Zhang
Xiao-Yan Sun
Wu-Hao Huang
Zhen-Fa Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.833866

2,767 views
3 citations

Original Research

Published on 08 Jun 2022

A Novel Score Combining Magnetic Resonance Spectroscopy Parameters and Systemic Immune-Inflammation Index Improves Prognosis Prediction in Non-Small Cell Lung Cancer Patients With Brain Metastases After Stereotactic Radiotherapy

in Thoracic Oncology

Dong Guo
Jiafeng Liu
Yanping Li
Qingqing Chen
Yunzheng Zhao
Xinwei Guo
Shuchai Zhu
Shengjun Ji

Frontiers in Oncology

doi 10.3389/fonc.2022.762230

1,746 views
2 citations

Case Report

Published on 08 Jun 2022

Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation

in Thoracic Oncology

Arsela Prelaj
Achille Bottiglieri
Gajanan Bhat
Rocky Washington
Giuseppina Calareso
Gabriella Francesca Greco
Roberto Ferrara
Marta Brambilla
Alessandro De Toma
Mario Occhipinti

Frontiers in Oncology

doi 10.3389/fonc.2022.902967

2,587 views
6 citations

Original Research

Published on 07 Jun 2022

Targeting ALK in Neuroendocrine Tumors of the Lung

in Thoracic Oncology

Dilara Akhoundova
Martina Haberecker
Ralph Fritsch
Sylvia Höller
Michael K. Kiessling
Markus Rechsteiner
Jan H. Rüschoff
Alessandra Curioni-Fontecedro

Frontiers in Oncology

doi 10.3389/fonc.2022.911294

3,958 views
12 citations

Correction

Published on 07 Jun 2022

Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study

in Thoracic Oncology

Mark M. Awad
Yvan Le Bruchec
Brian Lu
Jason Ye
Julie Ann Miller
Patrick H. Lizotte
Megan E. Cavanaugh
Amanda J. Rode
Calin Dan Dumitru
Alexander Spira

Frontiers in Oncology

doi 10.3389/fonc.2022.889996

1,152 views
1 citation

Original Research

Published on 07 Jun 2022

Continuous Vaginal Bleeding Induced By EGFR-TKI in Premenopausal Female Patients With EGFR Mutant NSCLC

in Thoracic Oncology

Min Yu
Xiaoyu Li
Xueqian Wu
Weiya Wang
Yanying Li
Yan Zhang
Shuang Zhang
Yongsheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.805538

2,859 views
3 citations

Systematic Review

Published on 07 Jun 2022

Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysis

in Thoracic Oncology

Xiao-Fang Yi
Jun Song
Ruo-Lin Gao
Li Sun
Zhi-Xuan Wu
Shu-Ling Zhang
Le-Tian Huang
Jie-Tao Ma
Cheng-Bo Han

Frontiers in Oncology

doi 10.3389/fonc.2022.863666

3,288 views
6 citations

Original Research

Published on 06 Jun 2022

Cost-Effectiveness of 12 First-Line Treatments for Patients With Advanced EGFR Mutated NSCLC in the United Kingdom and China

in Thoracic Oncology

Haijing Guan
Chunping Wang
Chen Chen
Sheng Han
Zhigang Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.819674

4,484 views
5 citations

Original Research

Published on 02 Jun 2022

A Pilot Study of Radiomics Models Combining Multi-Probe and Multi-Modality Images of 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT for Differentiating Benign and Malignant Pulmonary Space-Occupying Lesions

in Thoracic Oncology

Fei Xie
Kun Zheng
Linwen Liu
Xiaona Jin
Lilan Fu
Zhaohui Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.877501

1,507 views
2 citations

Systematic Review

Published on 02 Jun 2022

Tumor Budding as a Marker for Poor Prognosis and Epithelial–Mesenchymal Transition in Lung Cancer: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Nishant Thakur
Muhammad Joan Ailia
Yosep Chong
Ok Ran Shin
Kwangil Yim

Frontiers in Oncology

doi 10.3389/fonc.2022.828999

2,351 views
11 citations

Navigation group

Articles

Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma

A Prognostic Model of Non-Small Cell Lung Cancer With a Radiomics Nomogram in an Eastern Chinese Population

Beyond Crizotinib: A Systematic Review and Meta-Analysis of the Next-Generation ALK Inhibitors as First-Line Treatment for ALK-Translocated Lung Cancer

Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

The Applicability of the Results in the Asian Population of ORIENT-11 to a Western Population According to the ICH-E5 Framework

Platelet Activation in High D-Dimer Plasma Plays a Role in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Mutant Lung Adenocarcinoma

Plasma CXCL14 as a Candidate Biomarker for the Diagnosis of Lung Cancer

A Novel Score Combining Magnetic Resonance Spectroscopy Parameters and Systemic Immune-Inflammation Index Improves Prognosis Prediction in Non-Small Cell Lung Cancer Patients With Brain Metastases After Stereotactic Radiotherapy

Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation

Targeting ALK in Neuroendocrine Tumors of the Lung

Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study

Continuous Vaginal Bleeding Induced By EGFR-TKI in Premenopausal Female Patients With EGFR Mutant NSCLC

Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysis

Cost-Effectiveness of 12 First-Line Treatments for Patients With Advanced EGFR Mutated NSCLC in the United Kingdom and China

A Pilot Study of Radiomics Models Combining Multi-Probe and Multi-Modality Images of 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT for Differentiating Benign and Malignant Pulmonary Space-Occupying Lesions

Tumor Budding as a Marker for Poor Prognosis and Epithelial–Mesenchymal Transition in Lung Cancer: A Systematic Review and Meta-Analysis